85 related articles for article (PubMed ID: 16360886)
1. CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression.
Gärtner D; Hoff H; Gimsa U; Burmester GR; Brunner-Weinzierl MC
J Neuroimmunol; 2006 Mar; 172(1-2):73-84. PubMed ID: 16360886
[TBL] [Abstract][Full Text] [Related]
2. Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis.
Matsumoto Y; Sakuma H; Kohyama K; Park IK
J Neuroimmunol; 2007 Jul; 187(1-2):44-54. PubMed ID: 17499858
[TBL] [Abstract][Full Text] [Related]
3. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
5. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
6. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.
Mahajan D; Wang Y; Qin X; Wang Y; Zheng G; Wang YM; Alexander SI; Harris DC
J Am Soc Nephrol; 2006 Oct; 17(10):2731-41. PubMed ID: 16988067
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.
Fernandez-Martin A; Gonzalez-Rey E; Chorny A; Ganea D; Delgado M
Eur J Immunol; 2006 Feb; 36(2):318-26. PubMed ID: 16402407
[TBL] [Abstract][Full Text] [Related]
8. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
[TBL] [Abstract][Full Text] [Related]
9. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
[TBL] [Abstract][Full Text] [Related]
10. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.
Liu R; Bai Y; Vollmer TL; Bai XF; Jee Y; Tang YY; Campagnolo DI; Collins M; Young DA; La Cava A; Shi FD
Exp Neurol; 2008 May; 211(1):14-24. PubMed ID: 18353312
[TBL] [Abstract][Full Text] [Related]
11. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
12. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
13. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
14. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
Fecci PE; Ochiai H; Mitchell DA; Grossi PM; Sweeney AE; Archer GE; Cummings T; Allison JP; Bigner DD; Sampson JH
Clin Cancer Res; 2007 Apr; 13(7):2158-67. PubMed ID: 17404100
[TBL] [Abstract][Full Text] [Related]
15. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
16. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
[TBL] [Abstract][Full Text] [Related]
20. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
